Cerebrospinal fluid (CSF) and plasma pharmocokinetics of liposomal cytarabine (DepoCyte) after intrathecal administration in children with malignant brain tumors and leptomeningeal dissemination.
Phase of Trial: Phase II
Latest Information Update: 23 Jun 2015
At a glance
- Drugs Cytarabine (Primary)
- Indications Brain cancer; Carcinomatous meningitis
- Focus Pharmacokinetics
- 16 Oct 2013 Status changed from recruiting to completed according to results published in the Clinical Pharmacokinetics.
- 11 Jul 2011 New trial record